Background/Aims: Acute myocardial infarction is a serious disease with high morbidity and mortality. microRNAs (miRNAs) have been proved to play an important role in modulating myocardial ischemia and reperfusion injury. Hence, in this study, we constructed H9c2 cell model to elucidate the roles of microRNA-486 (miR-486) in preventing hypoxia-induced damage in H9c2 cells. Methods: H9c2 cells were cultured in hypoxic incubator with 1% O 2 to simulate hypoxia and/or transfected with miR-486 mimic, scramble, anti-miR-486, si-Nmyc downstream-regulated gene 2 (NDRG2) and their corresponding negative controls (NC). Effects of miR-486 and/or NDRG2 dysregulation on hypoxia-induced myocardial injury in H9c2 cells were investigated by evaluating cell viability, migration, invasion and apoptosis using Cell Counting Kit-8 (CCK-8), transwell assay, flow cytometry, respectively. The proteins expression and RNA expression were detected by western blot and quantitative real time polymerase chain reaction (qRT-PCR), respectively. Results: Hypoxia treatment induced damage in H9c2 cells by decreasing cell viability, migration and invasion and increasing cell apoptosis. Moreover, hypoxia inhibited the expression of miR-486 in H9c2 cells. Overexpression of miR-486 alleviated hypoxia-induced myocardial injury in H9c2 cells, while suppression of miR-486 further aggravated hypoxia-induced injury. Furthermore, NDRG2 expression was negatively regulated by miR-486, and NDRG2 was confirmed as a target of miR-486. Knockdown of NDRG2 alleviated the effects of miR-486 suppression on hypoxia-induced myocardial injury. Besides, knockdown of NDRG2 markedly inhibited the activation of c-Jun N-terminal kinase (JNK) /c-jun and nuclear factor κB (NF-κB) signaling pathways in hypoxia-induced H9c2 cells. Conclusion: Our findings indicate that miR-486 may alleviate hypoxia-induced myocardial
Introduction
Acute myocardial infarction (AMI) is the leading cause of mortality worldwide [1] . It is characterized by the insufficient of blood flow to heart and subsequently damage to the heart muscle. Patients with AMI always have several coronary plaques that are associated with adverse clinical outcomes [2] . In addition, ischemia and reperfusion (I/R) injury is a common cause of myocardial infarction [3] . Several therapeutic strategies that can protect against myocardial I/R injury are found to have a potential to improve clinical outcomes in patients with AMI [4, 5] . Therefore, elucidation of key mechanism preventing myocardial I/R injury will help to design an effective therapy for AMI.
As endogenous regulators of multiple target genes, microRNAs (miRNAs) have been identified to play crucial roles in modulating myocardial I/R injury [6] . For instance, miR-141 can attenuate myocardial I/R injury through regulation of intercellular adhesion molecule (ICAM)-1 expression and inflammatory cells infiltration [7] . Overexpression of miR-195 can promote cardiomyocyte apoptosis caused by myocardial I/R injury [8] . Downregulation of miR-320 can protect against myocardial I/R injury by inhibiting cardiomyocyte apoptosis and targeting insulin-like growth factor-1 (IGF-1) [9] . Upregulation of miR-22 can interfere with the mitochondrial function to aggravate I/R-induced mitochondrial damage [10] . Recently, miR-486 has been identified as a key regulator in the development of various cancers, including gastric cancer [11] , cervical cancer [12] and prostate cancer [13] . Notably, miR-486-3p can differentiate patients with 3-month ST-elevated acute myocardial infarction from those with stable ischemic heart disease, indicating that miR-486-3p may be a stability marker in acute coronary syndrome [14] . However, the role and regulatory mechanism of miR-486 in preventing cardiomyocytes from hypoxia-induced damage is largely unknown.
Hypoxia is one of the leading causes of tissue fibrosis. Hypoxia can induce transformation of phenotype of H9c2 cells; and myocardial cell migration and invasion are involved in the development of myocardial fibrosis because matrix metalloproteinases (MMPs), such as MMP-2 and MMP-9 are important factors not only on regulation of migration and invasion but also on fibrosis [15, 16] . Therefore, we detected migration and invasion of H9c2 cells induced by hypoxia.
In this study, H9c2 cells were exposed to hypoxia for modelling myocardial injury in vitro. The expression of miR-486 under hypoxia was determined, and the effects of miR-486 dysregulation on hypoxia-induced myocardial injury in H9c2 cells were investigated by evaluating cell viability, migration, invasion and apoptosis. In addition, the regulatory relationship between miR-486 and N-myc downstream-regulated gene 2 (NDRG2) was detected. Besides, whether the role of miR-486-NDRG2 axis in preventing hypoxia-induced myocardial injury was mediated by c-Jun N-terminal kinase (JNK/c-jun) and nuclear factor kappa B (NF-κB) signaling pathways was further explored. The findings of our study will elucidate the roles of miR-486 in preventing hypoxia-induced myocardial injury, with the goal of identifying potential therapies for treating ischemic myocardial injury following AMI. 
Materials and Methods

Cell culture and treatment
The H9c2 cells that were derived from rat embryonic ventricular cardiomyocytes were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). H9c2 cells were then cultured in Dulbecco's modified Eagle medium (DMEM, Gibco, Carlsbad, CA, USA) supplemented with 10% (v/v) fetal bovine serum (FBS, Life Science, UT, USA) and maintained in a 37°C incubator containing 95% air and 5% CO 2 . To simulate hypoxia, H9c2 cells were cultured in hypoxic incubator with the atmosphere of 94% N 2 , 1% O 2 , and 5% CO 2 .
Cell transfection miR-486 mimic, scramble, antianti-miR-486, si-NDRG2 and their corresponding negative controls (NC) were synthesized by GenePharma Co. (Shanghai, China), and then transfected into H9c2 cells using Lipofectamine 3000 reagent (Invitrogen, Carlsbad, CA, USA) following manufacturer's protocal.
Cell Counting Kit-8 (CCK-8) assay
Cell viability was determined by a CCK-8 (Dojindo Molecular Technologies, Gaithersburg, MD). Briefly, cells were seeded in 96-well plate with the density of 5000 cells/well. After transfection for 48 h, the CCK-8 solution was added to incubate cells for 1 h at 37°C. The absorbance of each well was measured at 450 nm with a Microplate Reader (Bio-Rad, Hercules, CA). Each determination was performed three times.
Migration and invasion assays
Cell migration and invasion was evaluated with transwell assay. For cell invasion and migration, the transwell chamber was precoated with Matrigel (BD Biosciences). Briefly, cells suspended in serum-free medium were seeded into the upper compartment of a 24-well transwell chamber with a pore size of 8 μm, and the lower compartment of chamber were filled with complete medium containing 10% FBS. After 48 h of incubation at 37°C, non-traversed cells were removed with a cotton swab and the migrated or invaded cells on the lower side of the chamber were fixed in 100% methanol, stained with crystal violet and counted.
Apoptosis assay
Flow cytometry analysis was carried out to detect cell apoptosis following double staining with Annexin V-fluorescein isothiocyanate (FITC) and propidium iodide (PI). Briefly, H9c2 cells were seeded in a 6 well-plate with the density of 100, 000 cells/well. Treated cells were washed twice with cold phosphate buffered saline (PBS) and resuspended in buffer. Double staining with Annexin V-FITC and PI was then conducted by means of Annexin V-FITC/PI apoptosis detection kit (Beijing Biosea Biotechnology, Beijing, China) according to the manufacturer's instruction. Apoptotic cells (Annexin-V positive and PI-negative) were then identified and quantified with a flow cytometer (Beckman Coulter, USA).
Luciferase reporter assay
The NDRG2 3'UTR carrying a putative miR-486-binding site was generated by PCR and then cloned into pMiR-report vector to establish the luciferase reporter constructs NDRG2-wild-type (NDRG2-WT). Subsequently, cells were co-transfected with the reporter constructs NDRG2-WT or control vector and miR-486 or scramble using Lipofectamine 3000 (Life Technologies, USA). For determination of the luciferase activity, reporter assays were done using the dual-luciferase assay system (Promega, Madison, WI, USA).
Western blot assay
Total protein used for western blot was extracted using RIA lysis buffer (Beyotime Biotechnology, Shanghai, China) containing protease inhibitors (Roche, Guangzhou, China). The concentration of protein extracts was then measured using the BCA™ Protein Assay Kit (Pierce, Appleton, WI, USA). Using a BioRad Bis-Tris Gel system, western blot assay was performed, followed by transferring into Polyvinylidene Difluoride (PVDF) membrane. Primary antibodies to B-cell lymphoma 2 (Bcl-2) (1:1, 000; Cell Signaling Technology), Bcl-2-associated X protein (Bax) (1:1, 000; Cell Signaling Technology), cleaved caspase-3 (1:1, 000; Cell Signaling Technology), pro-caspase-3 (1:1, 000; Cell Signaling Technology), cleaved caspase-9 (1:1, 000; Cell Signaling Technology), pro-caspase-9 (1:1, 000; Cell Signaling Technology), NDRG2 
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was isolated from cells using Trizol reagent (Invitrogen) following the manufacturer's instructions. To detect the relative expression of miR-486, the Taqman MicroRNA Reverse Transcription Kit and Taqman Universal Master Mix II with the TaqMan MicroRNA Assay of miR-486 and U6 (Applied Biosystems, Foster City, CA, USA) were used. To determine the relative expression of NDRG2, the One Step SYBR® PrimeScript®PLUS RT-RNA PCR Kit (TaKaRa Biotechnology, Dalian, China) was used. The U6 and GAPDH were used as the internal controls for normalizing the expression of miR-486 and NDRG2, respectively. Fold changes were calculated by the 2 −ΔΔCT method.
Statistical analysis
All experiments were repeated at least three times. The data collected from multiple experiments are presented as the mean ± standard deviation (SD). Significant difference was measured by calculating the P-values using a one-way analysis of variance (ANOVA) in SPSS 19.0 statistical software (SPSS Inc., Chicago, IL). Post-hoc Tukey test was carried to analyze the difference between two groups. A value of P < 0.05 indicated a statistically significant result.
Results
Hypoxia induced myocardial injury in H9c2 cells
The in vitro model of myocardial injury was constructed by hypoxia treatment. The results showed that hypoxia treatment resulted in the significantly decreases in H9c2 cell viability, migration and invasion (P < 0.05; Fig. 1A-C) and markedly increase in the cell apoptosis (P < 0.001; Fig. 1D) . Moreover, the expression of apoptosis-related proteins exhibited consistent changes: the expressions of Bcl-2 were significantly downregulated after hypoxia treatment (Fig.  1E) . These data indicated that hypoxia induced myocardial injury in H9c2 cells.
Hypoxia inhibited the expression of miR-486 in H9c2 cells
To detect whether miR-486 was involved in hypoxia induced myocardial injury, the expression of miR-486 in hypoxia-treated H9c2 cells was determined. Compared to control cells, miR-486 expression was significantly decreased in H9c2 cells after hypoxia treatment (P < 0.05, Fig. 2 ).
Overexpression of miR-486 alleviated hypoxiainduced myocardial injury in H9c2 cells
To further investigate the role of miR-486 in hypoxia-induced myocardial injury, miR-486 was overexpressed and suppressed in the hypoxia-treated H9c2 cells by cell transfections, and the highly transfection efficiency was confirmed by qRT-PCR (P < 0.01; Fig.  3A) . Next, it was found that miR-486 overexpression could improve the viability of non-hypoxic cells (P < 0.05; Fig. 3B ), indicating that miR-486 was an important regulator in H9c2 cells. Moreover, the results showed that overexpression of miR-486 significantly reversed hypoxia-induced myocardial injury by promoting H9c2 cell viability, migration and invasion (P < 0.05; Fig. 3C-3E ), while suppression of miR-486 further aggravated hypoxia-induced myocardial injury (P < 0.05; Fig. 3C-3E) . Furthermore, overexpression of miR-486 markedly inhibited hypoxiainduced cell apoptosis (P < 0.05; Fig. 3F and 3G) as well as the expression levels of Bax/Bcl-2, active-caspase-3 and active-caspase-9 (Fig. 3G) , whereas suppression of miR-486 aggravated hypoxia-induced myocardial injury by promoting cell apoptosis and the expression of apoptosis-related proteins (Fig. 3F and 3G) . These results revealed that overexpression of miR-486 might alleviate hypoxia-induced myocardial injury in H9c2 cells. 
NDRG2 expression was negatively regulated by miR-486, and NDRG2 was confirmed as a target of miR-486
To explore the possible regulatory mechanism of miR-486, the expression of NDRG2 at both mRNA and protein levels was detected. The results showed that NDRG2 expression in miR-486 mimic group was significantly lower than that in scramble group, while that in anti-miR-486 group was markedly higher than that in anti-NC group (P < 0.05; Fig. 4A and 4B) . Moreover, luciferase reporter assay was performed to confirm the regulatory relationship between miR-486 and NDRG2. Expected results were obtained that miR-486 mimic significantly inhibited the luciferase activity of NDRG2-WT (P < 0.05; Fig. 4C ), indicating that NDRG2 was a target of miR-486.
Knockdown of NDRG2 alleviated the effects of miR-486 suppression on hypoxia-induced myocardial injury
To investigate whether the effects of miR-486 on hypoxia-induced myocardial injury were mediated by NDRG2, we knocked down the expression of NDRG2 in hypoxia-treated and anti-miR-486-transfected H9c2 cells. The results showed that the effects of miR-486 suppression on the decreased hypoxia-treated H9c2 cell viability, migration and invasion as well as the increased cell apoptosis were significantly reversed by knockdown of NDRG2 (P < 0.05; Fig. 5A-5D) . Moreover, the decreased expressions of Bcl-2 and the increased expressions of Bax, cleaved-caspase-3 and cleaved-caspase-9 caused by miR-486 suppression were markedly reversed by NDRG2 knockdown concurrently (Fig. 5E ). These data indicated that knockdown of NDRG2 could alleviate the effects of miR-486 suppression on hypoxia-induced myocardial injury.
The miR-486-NDRG2 axis aggravated hypoxia-induced myocardial injury by activation of JNK/c-jun and NF-κB signaling pathways
To elucidate the possible mechanism of miR-486, the regulatory relationship between miR-486-NDRG2 axis and JNK/c-jun and NF-κB signaling pathways was further investigated. The results showed that the protein expression levels of NDRG2, p-JUN and p-c-Jun were significantly decreased in hypoxia+anti-miR-486+siNDRG2 group compared with those in hypoxia or hypoxia+anti-miR-486 groups (Fig. 6A) . Moreover, the protein expression levels of NDRG2, p-p65 and p-IκBα in hypoxia+anti-miR-486+siNDRG2 group were also significantly lower than those in hypoxia or hypoxia+anti-miR-486 groups (Fig. 6B) . These data indicated that the miR-486-NDRG2 axis may aggravate hypoxia-induced myocardial injury possibly by activation of JNK/c-jun and NF-κB signaling pathways. 
Discussion
In the present study, we preliminary investigated the role and regulatory mechanism of miR-486 in regulating hypoxia-induced damage in H9c2 cells. The results showed that hypoxia induced cell injury in H9c2 cells by decreasing cell viability, migration, invasion and increasing cell apoptosis. Furthermore, hypoxia inhibited the expression of miR-486 in H9c2 cells. Further experiments were performed to investigate the function of miR-486. Results demonstrated that overexpression of miR-486 alleviated hypoxia-induced myocardial injury in H9c2 cells by increasing cell viability, migration, and invasion while decreasing cell apoptosis. On the other hand, suppression of miR-486 further aggravated hypoxia-induced injury. These results were consistent with previous studies that transfecting of miR-486-5p could reduce ischemic kidney injury [17] and miR-486 attenuated cardiac myocyte damage in vitro [18] . In addition, miR-486 is a potent modulator in cardiac/skeletal muscle [19] and studies from Zhang et al. found that upregulation of circulating miR-486 in AMI patients may be related to cardiac hypertrophy [20] . Our study provided evidence which was consistent with Zhang et al. that miR-486 alleviated myocardial injury.
Furthermore, NDRG2 expression was negatively regulated by miR-486, and NDRG2 was confirmed as a target of miR-486. Knockdown of NDRG2 alleviated the effects of miR-486 suppression on hypoxia-induced myocardial injury. Besides, knockdown of NDRG2 markedly inhibit the activation of JNK/c-jun and NF-κB signaling pathway in hypoxia-treated H9c2 cells. These finding implied the important function of miR-486 in regulating ischemic myocardial injury.
As we all known, miRNAs always play their roles in many pathological processes via regulating the expression of their target genes [21, 22] . In this study, NDRG2 was confirmed as a target of miR-486 and NDRG2 expression could be negatively regulated by miR-486. NDRG2 is proposed to be a tumor suppressor gene that plays a key role in the development of diverse human cancers [23] [24] [25] [26] . Interestingly, a previous study had discovered that NDRG2 in the heart is modulated by myocardial I/R and may be involved in I/R-induced cardiac tissue injury [27] . Moreover, NDRG2 was suggested as a key mediator of insulin cardioprotection against myocardial I/R injury [28] . Considering the regulatory relationship between miR-486 and NDRG2, we speculate that miR-486 may modulate hypoxia-induced damage in H9c2 cells by regulating NDRG2 expression.
Furthermore, mitochondrial JNK activation is shown to induce autophagy and apoptosis and subsequently aggravate myocardial I/R injury [29] . It is also reported that the ubiquitin ligase muscle ring finger-1 can prevent cardiac I/R injury by blocking JNK signaling through degradation of phospho-c-Jun [30] . Moreover, Sato et al. suggested that grape seed proanthocyanidin could inhibit the apoptosis of cardiomyocytes through suppressing I/Rinduced activation of JNK-1 and c-jun [31] . These findings confirm the key role of JNK/cjun signaling in protecting against ischemic myocardial injury. In addition, inhibition of NF-κB was found to attenuate Beclin 1-mediated autophagy and thus alleviated I/R-induced myocardial injury [32] . Administration of sophocarpine could protecte myocardial injury from I/R in rats via inactivation of NF-κB [33] . Also, a NF-κB inhibitor BAY 11-7082 could inhibit inflammation and apoptosis in a rat cardiac I/R model, thus reducing the risk of myocardial injury caused by I/R [34] . Notably, loss of NDRG2 contributes to the development of adult T-cell leukemia/lymphoma and many other cancers through enhancing activation of the NF-κB pathway [25] . In our study, knockdown of NDRG2 markedly inhibited the activation of JNK/c-jun and NF-κB signaling in hypoxia-treated H9c2 cells. Therefore, we speculate that NDRG2 may regulate hypoxia-induced myocardial injury in H9c2 cells possibly by involving in JNK/c-jun and NF-κB signaling pathways. 
Conclusion
Our findings indicated that downregulation of miR-486 may aggravate hypoxia-induced myocardial injury in H9c2 cells possibly by targeting NDRG2 to activate JNK/c-jun and NF-κB signaling pathways. miR-486 may be a potential target for treating ischemic myocardial injury following acute myocardial infarction.
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